Insight

Ilana Schlam: Great review led by Tess O’Meara on ADCs in breast cancer

Collage photo of Ilana Schlam and Tess O'Meara

Jan 12, 2025, 06:34

Ilana Schlam: Great review led by Tess O’Meara on ADCs in breast cancer

A recent paper by Tess O’Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, was mentioned by Ilana Schlam, Breast Medical Oncologist at Dana-Farber Cancer Institute, on X:

“Great review led by Tess O’Meara on the available data and challenges of sequencing ADCs in breast cancer.”

“Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing”

Authors: Tess O’Meara, Paolo Tarantino, Stefania Morganti, Ilana Schlam, Ana Garrido-Castro, Sara Tolaney.

Ilana Schlam, MD, is a Breast Medical Oncologist at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Tufts University Medical Center. Her research focuses on precision medicine, drug development, and addressing healthcare disparities in breast cancer treatment and outcomes.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28

Insight

OncoDaily

Insight

Ilana Schlam: Great review led by Tess O’Meara on ADCs in breast cancer